The Institute for Biotechnology and Medicine Industry said Tuesday it has developed a safer and more convenient vaccine against human respiratory syncytial virus (RSV), which causes tens of millions of infections worldwide every year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Hualien to order mandatory evacuation ahead of possible storm
10/14/2025 07:57 PM - Culture
- Society
Steel corrosion suspected in Taichung balcony collapse
10/14/2025 07:04 PM - Science & Tech
Hon Hai teams up with Nvidia on AI factory infrastructure development
10/14/2025 06:40 PM - Society
Flu visits fall 10% over long weekend, likely due to clinic closures: CDC
10/14/2025 06:03 PM